WEBULL
WebtradeDownload

Here's What Analysts Are Forecasting For ORIOR AG (VTX:ORON) After Its Half-Year Results

Simply Wall St · 3d ago

There's been a notable change in appetite for ORIOR AG (VTX:ORON) shares in the week since its interim report, with the stock down 13% to CHF13.94. It was a credible result overall, with revenues of CHF283m and statutory earnings per share of CHF1.43 both in line with analyst estimates, showing that ORIOR is executing in line with expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth
SWX:ORON Earnings and Revenue Growth August 29th 2026

Following the recent earnings report, the consensus from three analysts covering ORIOR is for revenues of CHF578.9m in 2026. This implies a small 3.7% decline in revenue compared to the last 12 months. Statutory earnings per share are expected to nosedive 56% to CHF0.86 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of CHF594.1m and earnings per share (EPS) of CHF1.18 in 2026. The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a large cut to earnings per share numbers.

Check out our latest analysis for ORIOR

Despite the cuts to forecast earnings, there was no real change to the CHF13.07 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic ORIOR analyst has a price target of CHF16.20 per share, while the most pessimistic values it at CHF11.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await ORIOR shareholders.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that revenue is expected to reverse, with a forecast 7.3% annualised decline to the end of 2026. That is a notable change from historical growth of 0.1% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 3.1% annually for the foreseeable future. It's pretty clear that ORIOR's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for ORIOR. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. The consensus price target held steady at CHF13.07, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple ORIOR analysts - going out to 2028, and you can see them free on our platform here.

You still need to take note of risks, for example - ORIOR has 4 warning signs (and 2 which are a bit concerning) we think you should know about.